Results 221 to 230 of about 61,853 (265)

Neuroimaging of Parkinson’s disease and atypical parkinsonism

Current Neurology and Neuroscience Reports, 2004
The basal ganglia and its associated circuitry can be assessed with a variety of neuroimaging methods that can provide information regarding specific neurotransmitter systems, the functional activity of brain regions, and the structural integrity of these regions.
Dennis J, Zgaljardic, Andrew, Feigin
openaire   +2 more sources

Neuropathology of Parkinson's Disease and Parkinsonism

Cold Spring Harbor Perspectives in Medicine
Parkinsonism, the clinical term for a disorder with prominent bradykinesia and variably associated extrapyramidal signs and symptoms, is virtually always accompanied by degeneration of the nigrostriatal dopaminergic system, with neuronal loss and gliosis in the substantia nigra at autopsy.
openaire   +2 more sources

Cardiac abnormalities in Parkinson’s disease and Parkinsonism

Journal of Clinical Neuroscience, 2018
Though there is increasing evidence for primary cardiac disease in Parkinson's disease (PD) and Parkinsonism (PS), this evidence is hardly included in the general management of these patients.Literature review.PD is one of the most common age-related neurodegenerative disorders. Epidemiological studies have shown that PD is accompanied by high rates of
Fulvio A, Scorza, Ana C, Fiorini, Carla A, Scorza, Josef, Finsterer   +3 more
openaire   +2 more sources

Parkinsonism and Parkinson's disease.

Nurse practitioner forum, 1997
Parkinsonism is a disabling disorder frequently noted in the elderly. Its prevalence increases with age and has been associated with an increased risk of mortality. Appreciation of certain presenting and characteristic symptoms aids in determining the appropriate cause and treatment strategies.
K A, Janko, K M, Shannon
openaire   +1 more source

Parkinson's disease, Parkinsonism and aging

Archives of Gerontology and Geriatrics, 2002
NICITA MAURO, Vittorio, BASILE, Giorgio, MENTO A, EPIFANIO A, MARTINO, GABRIELLA, MORGANTE, Letterio   +5 more
openaire   +3 more sources

Manganese‐Induced Parkinsonism and Parkinson's Disease

Annals of the New York Academy of Sciences, 2004
Abstract: It has long been appreciated that manganese exposure can cause neurotoxicity and a neurologic syndrome that resembles Parkinson's disease (PD). Current evidence indicates that manganese‐induced parkinsonism can be differentiated from PD because of its predilection to accumulate in and damage the pallidum and striatum rather than the SNc. The
openaire   +2 more sources

Neuroimaging and Sleep Dysfunction in Parkinson’s and Parkinsonisms

Sleep Medicine Clinics
The article summarizes neuroimaging studies carried out during the last 2 decades to investigate the mechanisms underlying sleep dysfunction in Parkinson's and other synucleinopathies. Rapid eye movement sleep behavior disorder and excessive daytime sleepiness are discussed, as they are the most frequently investigated.
Zheyu, Xu, Nicola, Pavese, Rhia, Ghosh, Kit, Wu   +3 more
openaire   +2 more sources

The Parkinson disease before James Parkinson

Neurological Sciences, 2011
The first formal description of the Shaking Palsy is ascribed to James Parkinson. However, a review of the literature shows that several civilizations had know this disease from long before, despite the fact it was often mistaken for other diseases. Equally, therapies of some effectiveness were prescribed since ancient times.
openaire   +2 more sources

Neurotoxins, parkinsonism and Parkinson's disease

Pharmacology & Therapeutics, 1987
J W, Langston, I, Irwin, G A, Ricaurte
openaire   +2 more sources

Parkinson’s disease and parkinsonism

Abstract This chapter discusses the evidence-based pharmacological management of motor and non-motor (autonomic dysfunction, dementia, psychosis, depression, and sleep disorder) features of Parkinson’s disease (PD) and Parkinson’s plus syndromes (progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal ...
openaire   +1 more source